Developmental programming of metabolic diseases – a review of studies on experimental animal models

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2014, Vol 68, Issue

Abstract

Growth and development in utero is a complex and dynamic process that requires interaction between the mother organism and the fetus. The delivery of macro – and micronutrients, oxygen and endocrine signals has crucial importance for providing a high level of proliferation, growth and differentiation of cells, and a disruption in food intake not only has an influence on the growth of the fetus, but also has negative consequences for the offspring’s health in the future. Diseases that traditionally are linked to inappropriate life style of adults, such as type 2 diabetes, obesity, and arterial hypertension, can be “programmed” in the early stage of life and the disturbed growth of the fetus leads to the symptoms of the metabolic syndrome. The structural changes of some organs, such as the brain, pancreas and kidney, modifications of the signaling and metabolic pathways in skeletal muscles and in fatty tissue, epigenetic mechanisms and mitochondrial dysfunction are the basis of the metabolic disruptions. The programming of the metabolic disturbances is connected with the disruption in the intrauterine environment experienced in the early and late gestation period. It causes the changes in deposition of triglycerides, activation of the hormonal “stress axis” and disturbances in the offspring’s glucose tolerance. The present review summarizes experimental results that led to the identification of the above-mentioned links and it underlines the role of animal models in the studies of this important concept.

Authors and Affiliations

Iwona Piotrowska, Paulina Zgódka, Marta Milewska, Maciej Błaszczyk, Katarzyna Grzelkowska-Kowalczyk

Keywords

Related Articles

Role of CEACAM in neutrophil activation

Neutrophils express many surface adhesion molecules, including CEACAM1, CEACAM3, CEACAM4, CEACAM6 and CEACAM8 glycoproteins, which play an important role in biological functions of neutrophils such as adhesion, phagocyt...

Histone deacetylase inhibitors – molecular mechanisms of actions and clinical applications

Histone deacetylases (HDACs) play an important role in the epigenetic regulation of gene expression implicated in cancer pathogenesis. Inhibitors of HDACs (HDI) are under investigation as novel anti-cancer drugs, which i...

The immunomodulatory role of plant polyphenols

Polyphenols, plant secondary metabolites, are present in human diet and have been widely used for medical and cosmetic purposes. They possess beneficial features such as antioxidant, immunomodulatory, anti-cancer and ant...

Risk factors for skin cancer development in patients after organ transplantation

Cancer has become the second most common cause of death in patients after organ transplantation. Among all cancers arising de novo after transplantation skin cancers are the most common, accounting for 95% of all skin ne...

Ubiquitination, quality control and degradation of membrane proteins – chance for therapies?

Plasma membrane integrity maintenance is crucial for cell survival. Plasma membrane proteins are under tight regulation and under certain conditions are actively removed from the membrane allowing cells to adapt to chang...

Download PDF file
  • EP ID EP67433
  • DOI -
  • Views 128
  • Downloads 0

How To Cite

Iwona Piotrowska, Paulina Zgódka, Marta Milewska, Maciej Błaszczyk, Katarzyna Grzelkowska-Kowalczyk (2014). Developmental programming of metabolic diseases – a review of studies on experimental animal models. Advances in Hygiene and Experimental Medicine, 68(), 899-911. https://europub.co.uk/articles/-A-67433